Avicanna is a Toronto-based commercial-stage biopharmaceutical company focused on cannabinoid-based products for the medical, pharmaceutical, and consumer health markets. The company combines research, clinical development, and commercialization, and says its scientific platform has supported more than 30 proprietary finished products.